305-468-3314
3650 NW 82nd Avenue, Suite 502, Miami, FL 33166

Kidney cancer is one of the 10 most common cancers in the U.S., with an estimated 80,450 new cases diagnosed nationally each year. If you’re in Miami weighing your options — including larger centers like Miami Cancer Institute — it’s worth knowing the numbers are genuinely encouraging for most patients: roughly two-thirds of cases are caught while the cancer is still confined to the kidney, where the 5-year relative survival rate reaches 93.3%.
Dr. Shirin Razdan is the director of the robotic surgery department at the Comprehensive Urological Surgery Institute in Miami, specializing in robotic and Single Port surgical treatment for kidney cancer. This guide covers what you need to know about diagnosis, treatment, and choosing where to get care.
| Statistic | What the Data Shows |
| New U.S. cases annually | About 80,450, among the 10 most common cancers nationwide |
| Lifetime risk | About 1 in 45 (2.2%) for men; lower for women |
| Sex distribution | About twice as common in men as in women |
| Diagnosed at localized stage | About 65.7% of cases |
| 5-year survival, localized stage | 93.3% |
| 5-year survival, all stages combined | 79.2% |
| Most common type | Renal cell carcinoma (RCC), accounting for about 90% of cases |
Robotic kidney cancer surgery is a precise, minimally invasive procedure that uses small incisions and magnified 3D visualization to remove tumors or affected kidney tissue, typically reducing pain and speeding recovery compared to traditional open surgery. Dr. Razdan creates individualized treatment plans based on each patient’s tumor characteristics, overall health, and personal goals, drawing on years of focused experience in robotic urologic oncology.
Kidney cancer develops when abnormal cells in the kidney multiply uncontrollably, most often forming renal cell carcinoma. Risk factors include smoking, obesity, high blood pressure, family history, and certain inherited genetic conditions. Early kidney cancer often causes no symptoms at all — many cases are first discovered incidentally during imaging ordered for an unrelated reason, which is exactly why the overall localized-stage survival rate is so favorable.
For a deeper look at the diagnostic process and what each imaging test reveals, see our guide to understanding kidney cancer from diagnosis to surgical treatment options.
| Treatment | What It Involves | Best For |
| Active surveillance | Regular imaging monitors a small tumor without immediate treatment | Small, slow-growing tumors, particularly in older patients |
| Robotic partial nephrectomy | Removes only the cancerous portion, preserving healthy kidney tissue | Tumors where preserving kidney function is a priority; see our guide to robotic partial nephrectomy for complex renal tumors |
| Robotic radical nephrectomy | Removes the entire kidney and surrounding tissue through small incisions | Larger or more centrally located tumors |
| Single Port robotic surgery | The entire procedure performed through one small incision | Appropriately selected patients wanting the least invasive option; learn more about Single Port robotic nephrectomy and faster recovery |
| Targeted therapy / immunotherapy | Systemic medication to control cancer that has spread | Advanced or metastatic disease, coordinated with medical oncology |
| Radiation therapy | Shrinks tumors or treats cancer that has spread elsewhere | Select cases, often alongside other treatments |
Kidney cancer survival is closely tied to the stage at diagnosis — our detailed guide to kidney cancer survival rates by stage (1 through 4) breaks down what each stage means and the associated outlook. As a general pattern, the earlier the diagnosis, the stronger the odds — which is a major reason persistent symptoms, or known risk factors, warrant prompt evaluation rather than a wait-and-see approach on your own.
Large academic cancer centers like Miami Cancer Institute offer genuine strengths — multidisciplinary teams, clinical trials, and national research affiliations. At the same time, many patients value working directly with a dedicated, board-certified urologic oncologist for a more personal, continuous relationship throughout diagnosis, surgery, and follow-up. When comparing your options, it’s reasonable to ask any surgeon or center directly about:
Seeking a second opinion is considered good medical practice, not a sign of distrust in any provider — and it’s one of the most valuable steps you can take before committing to a treatment plan, particularly for a diagnosis as consequential as cancer. If your long-term outlook is on your mind, our article on whether kidney cancer is curable walks through how stage and tumor characteristics shape that answer.
Yes. Robotic surgery is a well-established, effective approach for most kidney cancer cases, generally offering fewer complications and faster recovery than traditional open surgery when performed by an experienced surgeon.
Patients diagnosed with kidney cancer who are in reasonably good overall health and have a tumor that minimally invasive techniques can appropriately address are typically good candidates. Your surgeon will confirm suitability based on your specific imaging and health history.
Recovery varies by individual, but most robotic surgery patients return to light activity within a couple of weeks and resume most normal activities within several weeks — meaningfully faster than typical recovery after traditional open surgery.
It’s among the 10 most common cancers in both men and women in the U.S., with an estimated 80,450 new cases diagnosed nationally each year.
Overall, the 5-year relative survival rate across all stages is 79.2%. For cancer still confined to the kidney at diagnosis — about two-thirds of cases — survival rises to 93.3%.
Yes — a second opinion is widely considered good practice for any cancer diagnosis and can help confirm your diagnosis and clarify your options, regardless of which provider you ultimately choose for treatment.
Treatment for more advanced disease often combines surgery with systemic options like targeted therapy, immunotherapy, or radiation, coordinated between your surgeon and a medical oncology team as part of a complete treatment plan.
Small, slow-growing tumors — particularly in older patients or those with other significant health concerns — may be appropriate for active surveillance, where imaging monitors the tumor over time rather than treating it immediately. Your surgeon will help determine which approach fits your specific situation.
For more on what kidney cancer treatment costs and how survival rates break down further, see our complete guide to kidney cancer symptoms, survival rates, and treatment cost, or learn more about Dr. Razdan’s background on her about page.
© 2025 Miami Robotic Surgery. All rights reserved.